Evidence map›Paper›PMID 33335938›Full record

ArticleOpen forum infectious diseases2020

Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 Study.

Jiajun Liu, Steven Y C Tong, Joshua S Davis, Nathaniel J Rhodes, Marc H Scheetz, CAMERA2 Study Group

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Safe and effective use of vancomycin.Australian prescriber · 2025
    Review
  5. Protamine protects against vancomycin-induced kidney injury.Antimicrobial agents and chemotherapy · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve Monitoring.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiajun LiuMidwestern University Chicago College of Pharmacy, Downers Grove, Illinois, USA.ORCID 0000-0002-4330-2098
Steven Y C TongVictorian Infectious Diseases Service, The Royal Melbourne Hospital, and Doherty Department University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Joshua S DavisMenzies School of Health Research, Charles Darwin University, Darwin, Australia.ORCID 0000-0001-9864-5699
Nathaniel J RhodesMidwestern University Chicago College of Pharmacy, Downers Grove, Illinois, USA.ORCID 0000-0002-0018-5434
Marc H ScheetzMidwestern University Chicago College of Pharmacy, Downers Grove, Illinois, USA.
CAMERA2 Study Group

Funding

Quantifying renal injury among the most commonly used clinical antibiotic combinationsR21AI149026 · NIAID · MIDWESTERN UNIVERSITY · PI SCHEETZ, MARC HOWARD · 2020 to 2021
$413k
NIAID NIH HHS R21 AI149026
6 · The paper itself

Abstract

Among patients with methicillin-resistant

Indexed as

acute kidney injuryAUCcombination therapyMRSA bacteremianephrotoxicitypharmacokineticstoxicodynamicsvancomycinβ-lactam

Identifiers

PMID33335938
PMCPMC7731530

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.